We are live on ! Find out more
FIM

Fruth Investment Management Portfolio holdings

AUM $421M
1-Year Est. Return 35.14%
This Fund
S&P 500
This Quarter Est. Return
+15.4%
1 Year Est. Return
+35.14%
3 Year Est. Return
+70.99%
5 Year Est. Return
+103.83%
10 Year Est. Return
+381.74%
AUM
$341M
AUM Growth
+$40M
Cap. Flow
-$3.74M
Cap. Flow %
-1.1%
Top 10 Hldgs %
24.16%
Holding
226
New
6
Increased
5
Reduced
112
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 19.99%
2 Materials 13.4%
3 Energy 12.92%
4 Consumer Discretionary 12.26%
5 Consumer Staples 11.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
226
Vanguard Morningstar Total Stock Market ETF
VTI
$679B
-1,020
Closed -$183K

Similar funds

Fruth Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Fruth Investment Management held 226 positions worth $341M, up 13% from $301M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 3.5%. Fruth Investment Management opened 6 new positions and exited 2, leaving the 226-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Materials and Energy.

  • Fruth Investment Management's largest Q4 2022 buy was Texas Pacific Land: 900 shares worth $234K.
  • Fruth Investment Management added most to Goodyear in Q4 2022, an estimated $14.2K increase.
  • Fruth Investment Management's biggest Q4 2022 reduction was AbbVie, cutting an estimated $1.33M.
  • Fruth Investment Management fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2022, selling an estimated $183K.
  • Fruth Investment Management's ten largest holdings make up 24% of its $341M portfolio in Q4 2022.
  • Fruth Investment Management opened 6 new positions and closed 2 in Q4 2022.
  • Fruth Investment Management's portfolio value rose 13% quarter-over-quarter to $341M.

Based on Fruth Investment Management's 13F filing for Q4 2022, filed 17 Jan 2023.